Sugammadex

also known as Bridion · sugammadex sodium · MK-8616 · HengShu, Sugammadex sodium · Org 25969 · Org 25969, Bridion · SUG · Sugammadex adroiq · +6 more

Other / unclassified

Developed for: curariform drugs toxicity · morbid obesity · neuromuscular disease · obstructive sleep apnea syndrome · ileus · cranial nerves, recurrent paresis of · delirium · intestinal dysmotility syndrome
+10 more
· lung disorder · myopathy · pulmonary immaturity · respiratory paralysis · respiratory system disorder · urinary bladder disorder · urinary tract obstruction · voice disorders · intestinal disorder · ocular hypotension
Investigated by: Merck Sharp & Dohme LLC · Seoul National University Hospital · Guangzhou General Hospital of Guangzhou Military Command · Yonsei University · Ajou University School of Medicine · Onze Lieve Vrouw Hospital
+103 more
· Seoul National University Bundang Hospital · University Hospital Olomouc · University of Washington · Brno University Hospital · Campus-Bio-Medico University · Emory University · Korea University Anam Hospital · Leiden University Medical Center · M.D. Anderson Cancer Center · MSD Belgium BVBA · MSD Korea Ltd. · Mansoura University · Ministry of Food and Drug Safety, Korea · Oregon Health and Science University · Palacky University · Technical University of Munich · The Cleveland Clinic · Universitaire Ziekenhuizen KU Leuven · University of Missouri-Columbia · University of South Florida · Ain Shams University · Alexandria University · Baskent University · Beijing Tiantan Hospital · Beijing Tongren Hospital · Central Clinical Hospital #1 of LLC Russian Railways · Central Hospital, Nancy, France · Centro Hospitalar do Porto · Chang Gung Memorial Hospital · Chulalongkorn University · Ciusss de L'Est de l'Île de Montréal · Clayton Petro · Diskapi Teaching and Research Hospital · Endeavor Health · Enrique Alday Muñoz · Erasme University Hospital · Faculdade de Ciências Médicas da Santa Casa de São Paulo · Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Federal University of São Paulo · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Georgia Clinical & Translational Science Alliance · Guangdong Provincial Hospital of Traditional Chinese Medicine · Hadassah Medical Organization · Hopital Foch · Hospital General Universitario Santa Lucía · Hospital Sultanah Aminah Johor Bahru · Hospital Universitario Santa Maria del Rosell · Hospital Universitario Virgen de la Arrixaca · IGA - internal grant agency, Ministry of Health · KDCHOT FN Brno · Kaohsiung Medical University Chung-Ho Memorial Hospital · Korea University Ansan Hospital · Lütfiye Nuri Burat Government Hospital · Masaryk Hospital Usti nad Labem · Mayo Clinic · McMaster University · Medipol University · Merck Canada Inc. · Montefiore Medical Center · National Cancer Institute, Egypt · National Center for Advancing Translational Sciences (NCATS) · National Taiwan University Hospital · Padjadjaran University · Peking Union Medical College Hospital · Poitiers University Hospital · Pusan National University Yangsan Hospital · Radboud University Medical Center · Regina Elena Cancer Institute · Respiratory Motion, Inc. · Rhendra Hardy Mohamad Zaini · Rigshospitalet, Denmark · SMG-SNU Boramae Medical Center · all 109 on the full record

Regulatory milestones approvals, filings & regulatory actions · 6 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Label expansions (4)	US (FDA)	BRIDION	—	2020-06-09 – 2024-12-12	fda.gov ↗
Approved	US (FDA)	BRIDION	—	2015-12-15	fda.gov ↗
Approved	EU (EMA)	Bridion	—	2008-07-25	europa.eu ↗

Trials 159 · started per year

today

EU approved 2008

US approved 2015

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 14 trials
Phase 1	NCT04556721	Sep 2021	kidney disorder	Tetsuro Sakai	Withdrawn	No outcome recorded
Phase 1	NCT02028065	Jan → Jul 2014	anaphylaxis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 1	NCT02011490	Dec 2013 → Jun 2014	impaired renal function disease	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 1	NCT00988065	Sep 2009 → Apr 2010	hypersensitivity reaction disease	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 1/21 trial
Phase 1/2	NCT06794450	Nov 2024 → Feb 2025 overdue	curariform drugs toxicity	Padjadjaran University	Recruiting	No outcome recorded
Phase 217 trials
Phase 2	NCT06575036	Sep 2024 → Apr 2025 overdue	—	Sang-Hwan Ji	Not yet recruiting	No outcome recorded
Phase 2	NCT05723406	Mar → Nov 2023	osteoarthritis, hip	Radboud University Medical Center	Completed	No outcome recorded
Phase 2	NCT04347486	Apr 2020 → Dec 2021	—	Seoul National University Hospital	Completed	No outcome recorded
Phase 2	NCT03943888	Aug 2019 → Feb 2020	—	Seoul National University Hospital	Completed	No outcome recorded
Phase 2	NCT03532178	Jan 2019 → Mar 2022	—	University of California, San Francisco	Completed	No outcome recorded
Phase 2	NCT03519724	Jul → Sep 2018	curariform drugs toxicity	Campus-Bio-Medico University	Unknown	No outcome recorded
Phase 2	NCT03519633	Apr 2018 → Dec 2024	curariform drugs toxicity	Campus-Bio-Medico University	Completed	No outcome recorded
Phase 2	NCT02545595	May 2012 → Dec 2013	morbid obesity	Poitiers University Hospital	Completed	No outcome recorded
Phase 2	NCT01911520	Jan 2011 → Jun 2012	morbid obesity	University Hospital, Ghent	Completed	No outcome recorded
Phase 2	NCT00591409	Jan → Sep 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00591786	Dec 2005 → Aug 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00552929	Oct 2005 → Sep 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00552617	Sep 2005 → Aug 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT03519867	Aug 2004 → May 2005	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00535743	Mar → Jul 2004	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00379613	Nov 2003 → Jul 2004	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT03519854	Dec 2002 → Jun 2003	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded

Phase 2/31 trial
Phase 2/3	NCT03728543	Nov 2018 → Nov 2019	beta thalassemia, childhood malignant neoplasm, hepatoblastoma	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Unknown	No outcome recorded
Phase 332 trials
Phase 3	NCT07271875	Jan 2026 → Nov 2027 expected	ileus, intestinal dysmotility syndrome	Xijing Hospital	Not yet recruiting	No outcome recorded
Phase 3	NCT06136585	Jun 2024 → Oct 2026 expected	—	The Cleveland Clinic	Recruiting	No outcome recorded
Phase 3	NCT05801679	Jul 2023 → Jul 2025	—	Endeavor Health	Completed	No outcome recorded
Phase 3	NCT05276804	Apr 2022 → Sep 2024	urinary bladder disorder	Wake Forest University Health Sciences	Completed	No outcome recorded
Phase 3	NCT04854993	Jul 2021 → Sep 2022	prostate cancer	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Completed	No outcome recorded
Phase 3	NCT04096144	Oct 2019 → Mar 2020 overdue	—	University of South Florida	Not yet recruiting	No outcome recorded
Phase 3	NCT03196791	Oct 2017 → Aug 2020	gastric cancer, obesity disorder	Korea University Anam Hospital	Completed	No outcome recorded
Phase 3	NCT01570179	May → Jul 2012	—	Central Hospital, Nancy, France	Completed	No outcome recorded
Phase 3	NCT01509651	Jan → Mar 2012	—	Onze Lieve Vrouw Hospital	Completed	No outcome recorded
Phase 3	NCT01479764	Dec 2011 → Oct 2012	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT01422304	Oct 2011 → Sep 2012	blood coagulation disease, osteoarthritis, hip, osteoarthritis, knee	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT01809886	Oct 2011 → Oct 2013	—	Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Completed	No outcome recorded
Phase 3	NCT01050543	Feb → Aug 2010	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00826176	Jan → Aug 2010	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00825812	Jan → Sep 2010	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00758485	Oct 2008 → May 2009	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00702715	Sep 2008 → Mar 2010	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00724932	Jul 2008 → Apr 2009	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00675792	May → Sep 2008	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00656799	Apr 2008 → Jul 2009	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00535496	Sep 2007 → Jan 2008	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00559468	Dec 2006 → Mar 2007	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00474253	Feb → Aug 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00474617	Dec 2005 → Oct 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00473694	Nov 2005 → Nov 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00451217	Nov 2005 → Mar 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00451100	Nov 2005 → May 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00420680	Nov 2005 → Aug 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00475215	Oct 2005 → Aug 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00298831	Oct 2005 → May 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00482599	Jun 2005 → Apr 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00421148	May 2005 → May 2006	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded

Phase 470 trials
Phase 4	NCT07477132	Mar 2026 → Aug 2027 expected	curariform drugs toxicity	University Hospital, Caen	Not yet recruiting	No outcome recorded
Phase 4	NCT05985343	Jan 2024 → May 2025	abdominal wall malformation, ileus	Clayton Petro	Completed	No outcome recorded
Phase 4	NCT05887375	Aug 2023 → Jan 2026	urinary tract obstruction	University of Missouri-Columbia	Completed	No outcome recorded
Phase 4	NCT05661409	Jul 2023 → Aug 2024	—	Emory University	Completed	No outcome recorded
Phase 4	NCT05256901	Jul 2023 → Jul 2024	appendicitis	Emory University	Terminated	No outcome recorded
Phase 4	NCT05817019	Apr 2023 → Dec 2024	COVID-19	Korea University Ansan Hospital	Unknown	No outcome recorded
Phase 4	NCT05718934	Nov 2022 → Dec 2023	—	Ciusss de L'Est de l'Île de Montréal	Completed	No outcome recorded
Phase 4	NCT05354466	Jun 2022 → Sep 2024	respiratory system disorder	Seoul National University Hospital	Completed	No outcome recorded
Phase 4	NCT05328778	Apr 2022 → Jan 2025	—	Guangzhou General Hospital of Guangzhou Military Command	Completed	No outcome recorded
Phase 4	NCT04263363	Feb 2022 → May 2024	obstructive sleep apnea syndrome	University of California, Los Angeles	Completed	No outcome recorded
Phase 4	NCT05246397	Feb → Nov 2022	aortic disorder, coronary artery disorder, heart failure, heart valve disorder	University of Washington	Completed	No outcome recorded
Phase 4	NCT05187455	Jan → Nov 2022	—	Guangzhou General Hospital of Guangzhou Military Command	Unknown	No outcome recorded
Phase 4	NCT05028088	Jul 2021 → Dec 2022	liver disorder	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Unknown	No outcome recorded
Phase 4	NCT04546672	Mar 2021 → Jun 2023	bowel dysfunction	Oregon Health and Science University	Completed	No outcome recorded
Phase 4	NCT03923556	Feb 2021 → Sep 2023	curariform drugs toxicity	University of Colorado, Denver	Completed	No outcome recorded
Phase 4	NCT05202899	Sep 2020 → Feb 2022	brain neoplasm	Guangzhou General Hospital of Guangzhou Military Command	Unknown	No outcome recorded
Phase 4	NCT03909165	Jul 2019 → Sep 2023	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT04131218	Jul 2019 → Jul 2020	—	Guangzhou General Hospital of Guangzhou Military Command	Unknown	No outcome recorded
Phase 4	NCT03944473	Jun 2019 → Jul 2020	gait apraxia	Montefiore Medical Center	Withdrawn	No outcome recorded
Phase 4	NCT03996655	Jun → Sep 2019	curariform drugs toxicity	National Cancer Institute, Egypt	Unknown	No outcome recorded
Phase 4	NCT03958201	May 2019 → Jan 2020	respiratory paralysis	University of Washington	Completed	No outcome recorded
Phase 4	NCT03679611	Jan 2019 → Oct 2021	obstructive sleep apnea syndrome	University Health Network, Toronto	Completed	No outcome recorded
Phase 4	NCT03643913	Dec 2018 → Nov 2024	arthropathy	Universitaire Ziekenhuizen KU Leuven	Completed	No outcome recorded
Phase 4	NCT03543826	May → Nov 2018	myopathy	University of Washington	Completed	No outcome recorded
Phase 4	NCT03515694	Apr → Sep 2018	—	Erasme University Hospital	Completed	No outcome recorded
Phase 4	NCT03351608	Feb 2018 → Jan 2020	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT03346070	Jan 2018 → Jan 2019	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT03346057	Dec 2017 → Sep 2019	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT03210376	Nov 2017 → Sep 2018	digestive system cancer, female reproductive organ cancer, male reproductive organ cancer, malignant urinary system neoplasm	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 4	NCT03322657	Nov 2017 → Dec 2020	—	The Cleveland Clinic	Completed	No outcome recorded
Phase 4	NCT03138967	Sep 2017 → Sep 2018	urinary bladder cancer	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 4	NCT03039543	Jun → Nov 2017	—	Seoul National University Bundang Hospital	Completed	No outcome recorded
Phase 4	NCT03112993	May 2017 → Aug 2018	—	University of Missouri-Columbia	Completed	No outcome recorded
Phase 4	NCT03196167	May 2017 → Oct 2020	—	Yale University	Completed	No outcome recorded
Phase 4	NCT03144453	May 2017 → Dec 2019	—	Regina Elena Cancer Institute	Unknown	No outcome recorded
Phase 4	NCT03229486	Mar 2017 → Jul 2019	delirium	Pusan National University Yangsan Hospital	Completed	No outcome recorded
Phase 4	NCT02861131	Jan 2017 → Apr 2018	—	Oregon Health and Science University	Completed	No outcome recorded
Phase 4	NCT02845375	Sep 2016 → Sep 2018	respiratory failure	Leiden University Medical Center	Completed	No outcome recorded
Phase 4	NCT02484651	Sep 2016 → Jun 2017	neuromuscular disease	Centro Hospitalar do Porto	Completed	No outcome recorded
Phase 4	NCT02860507	Aug 2016 → Feb 2018	—	University of South Florida	Completed	No outcome recorded
Phase 4	NCT02728726	Jun 2016 → Dec 2019	—	Mayo Clinic	Completed	No outcome recorded
Phase 4	NCT02451202	Jun 2016 → Mar 2018	—	Chulalongkorn University	Completed	No outcome recorded
Phase 4	NCT03420937	Jun 2016 → Jun 2017	—	University Hospital Olomouc	Completed	No outcome recorded
Phase 4	NCT02648503	Mar → Sep 2016	neuromuscular disease	University of Medicine and Pharmacy at Ho Chi Minh City	Unknown	No outcome recorded
Phase 4	NCT02403063	Sep → Oct 2015	—	Onze Lieve Vrouw Hospital	Completed	No outcome recorded
Phase 4	NCT02410590	Jul 2015 → Oct 2016	—	Merck Sharp & Dohme LLC	Withdrawn	No outcome recorded
Phase 4	NCT02513693	Jul 2015 → Mar 2016	—	Palacky University	Unknown	No outcome recorded
Phase 4	NCT02580188	Mar 2015 → Jun 2016	—	Seoul National University Bundang Hospital	Completed	No outcome recorded
Phase 4	NCT02361060	Feb 2015 → Jul 2016	—	Enrique Alday Muñoz	Completed	No outcome recorded
Phase 4	NCT02329964	Feb → Aug 2015	—	Korea University Anam Hospital	Unknown	No outcome recorded
Phase 4	NCT02256280	Jan 2015 → Mar 2020	—	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Terminated	No outcome recorded
Phase 4	NCT02708056	Jan 2015 → Feb 2016	brain cancer	Baskent University	Completed	No outcome recorded
Phase 4	NCT02284412	Dec 2014	—	Onze Lieve Vrouw Hospital	Completed	No outcome recorded
Phase 4	NCT02698969	Nov 2014 → Feb 2017	curariform drugs toxicity	University of Florence	Unknown	No outcome recorded
Phase 4	NCT02243943	Sep 2014 → Apr 2016	lung disorder	Leiden University Medical Center	Completed	No outcome recorded
Phase 4	NCT02100280	Jun 2014 → Jun 2017	—	Seoul National University Bundang Hospital	Completed	No outcome recorded
Phase 4	NCT01965067	Oct 2013 → Feb 2014	—	MSD Korea Ltd.	Completed	No outcome recorded
Phase 4	NCT01761552	Aug 2013 → Dec 2015	—	Hadassah Medical Organization	Unknown	No outcome recorded
Phase 4	NCT01748643	Apr 2013 → Jan 2015	obesity disorder	Ziekenhuis Oost-Limburg	Completed	No outcome recorded
Phase 4	NCT02568345	Jan → Oct 2013	—	Faculdade de Ciências Médicas da Santa Casa de São Paulo	Completed	No outcome recorded
Phase 4	NCT01718236	Sep 2012 → Jan 2015	pregnancy disorder	Brno University Hospital	Completed	No outcome recorded
Phase 4	NCT01539044	Feb 2012 → Jun 2013	curariform drugs toxicity	Hospital Sultanah Aminah Johor Bahru	Completed	No outcome recorded
Phase 4	NCT02160223	Jan 2012 → Jun 2014	obstructive sleep apnea syndrome	Diskapi Teaching and Research Hospital	Completed	No outcome recorded
Phase 4	NCT01785758	Oct 2011 → Jan 2012	chronic renal failure syndrome	Federal University of São Paulo	Completed	No outcome recorded
Phase 4	NCT01424488	Sep 2011 → Feb 2012	—	Central Clinical Hospital #1 of LLC Russian Railways	Unknown	No outcome recorded
Phase 4	NCT01161004	Sep 2010 → Aug 2011	—	Hopital Foch	Completed	No outcome recorded
Phase 4	NCT01101139	Apr 2010 → May 2011	—	Technical University of Munich	Completed	No outcome recorded
Phase 4	NCT00953550	Sep 2009 → Jan 2011	—	Rigshospitalet, Denmark	Completed	No outcome recorded
Phase 4	NCT01142648	Apr 2009 → Mar 2010	—	Tampere University Hospital	Completed	No outcome recorded
Phase 4	NCT00895609	Mar → Aug 2009	neuromuscular disease	Technical University of Munich	Completed	No outcome recorded

Phase not applicable34 trials
—	NCT07534475	Apr → May 2026 overdue	bipolar disorder, major depressive disorder, schizophrenia	Medipol University	Not yet recruiting	No outcome recorded
—	NCT07309393	Dec 2025 → Sep 2026 expected	—	Shanghai Pulmonary Hospital, Shanghai, China	Recruiting	No outcome recorded
—	NCT06962007	Jul 2025 → Sep 2026 expected	facial spasm	Wonkwang University Hospital	Recruiting	No outcome recorded
—	NCT06634355	Mar 2025 → Sep 2026 expected	pregnancy disorder	Universitaire Ziekenhuizen KU Leuven	Enrolling by invitation	No outcome recorded
—	NCT06678451	Dec 2024 → May 2025 overdue	—	Shanxi Bethune Hospital	Not yet recruiting	No outcome recorded
—	NCT05751603	Oct 2024 → Oct 2025 overdue	—	Ajou University School of Medicine	Not yet recruiting	No outcome recorded
—	NCT06436768	Jun 2024 → Mar 2025	—	Beijing Tongren Hospital	Completed	No outcome recorded
—	NCT06334562	Jun 2024 → Dec 2025 overdue	—	The Fourth Affiliated Hospital of Zhejiang University School of Medicine	Recruiting	No outcome recorded
—	NCT06398899	May 2024 → Jun 2025	chronic otitis media, chronic rhinosinusitis, laryngeal disorder	National Taiwan University Hospital	Completed	No outcome recorded
—	NCT05993390	Jan 2024 → Aug 2027 expected	—	Seoul National University Hospital	Recruiting	No outcome recorded
—	NCT05724550	Feb 2023 → Jun 2024	curariform drugs toxicity	Seoul National University Hospital	Completed	No outcome recorded
—	NCT06210165	Dec 2022 → Jun 2024	pulmonary immaturity	Rhendra Hardy Mohamad Zaini	Unknown	No outcome recorded
—	NCT04997759	Sep 2021 → Aug 2022	—	Chang Gung Memorial Hospital	Unknown	No outcome recorded
—	NCT05040490	Aug 2021 → Jul 2022	—	Peking Union Medical College Hospital	Unknown	No outcome recorded
—	NCT04608682	Aug 2021 → Aug 2022	—	Beijing Tiantan Hospital	Completed	No outcome recorded
—	NCT04545099	Sep 2020 → Sep 2022	—	Yonsei University	Unknown	No outcome recorded
—	NCT04566796	Aug 2020 → Feb 2021	—	Alexandria University	Unknown	No outcome recorded
—	NCT04161508	Dec 2019 → Dec 2021	—	Taipei Veterans General Hospital, Taiwan	Unknown	No outcome recorded
—	NCT04407078	Dec 2019 → Jan 2021	gallbladder disorder	Ajou University School of Medicine	Completed	No outcome recorded
—	NCT03803982	Jan → Dec 2019	—	McMaster University	Unknown	No outcome recorded
—	NCT03689413	Oct 2018 → Aug 2019	—	Seoul National University Hospital	Completed	No outcome recorded
—	NCT03634956	Aug 2018 → Feb 2019	cranial nerves, recurrent paresis of, voice disorders	Lütfiye Nuri Burat Government Hospital	Unknown	No outcome recorded
—	NCT03583021	Jun → Oct 2018	gallbladder disorder	Ajou University School of Medicine	Completed	No outcome recorded
—	NCT03381209	Jun → Nov 2017	—	Ain Shams University	Completed	No outcome recorded
—	NCT03108989	Feb → Jul 2017	—	Yonsei University	Completed	No outcome recorded
—	NCT02939430	Nov 2016 → Oct 2017	—	Mansoura University	Unknown	No outcome recorded
—	NCT02762890	Oct 2016 → Feb 2017	—	Yonsei University	Completed	No outcome recorded
—	NCT02944175	Jul 2016 → Sep 2019	supratentorial cancer	Mansoura University	Unknown	No outcome recorded
—	NCT02546843	Dec 2015 → Sep 2018	—	Brno University Hospital	Completed	No outcome recorded
—	NCT03911232	Mar 2015 → Mar 2016	thyroid gland disorder	Kaohsiung Medical University Chung-Ho Memorial Hospital	Completed	No outcome recorded
—	NCT03137290	Dec 2014 → Jun 2016	—	Universiti Sains Malaysia	Completed	No outcome recorded
—	NCT02109133	May → Dec 2014	—	Yonsei University	Completed	No outcome recorded
—	NCT01890057	Jun 2013 → Jan 2014	—	Severance Hospital	Completed	No outcome recorded
—	NCT01564576	Apr → Aug 2012	morbid obesity	Sheba Medical Center	Unknown	No outcome recorded

Also used as a comparator or background therapy in 83 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 01 trial
Phase 0	NCT03328312 Comparator	Dec 2017 → Mar 2018	curariform drugs toxicity	Iuliu Hatieganu University of Medicine and Pharmacy	Unknown	No outcome recorded
Phase 13 trials
Phase 1	NCT06982092 Comparator	Aug 2024 → Jan 2025	—	Ain Shams University	Completed	No outcome recorded
Phase 1	NCT03579589 Comparator	Aug 2018 → Dec 2019	—	Ohio State University	Completed	No outcome recorded
Phase 1	NCT02888067 Comparator	Jul 2017 → Jul 2022	—	Thomas Schricker	Terminated	No outcome recorded
Phase 1/21 trial
Phase 1/2	NCT05664633 Comparator	Aug 2023 → Jun 2024	urinary bladder disorder	West Virginia University	Withdrawn	No outcome recorded
Phase 22 trials
Phase 2	NCT03904550 Comparator	Dec 2019 → Aug 2022	impaired renal function disease	University of Texas Southwestern Medical Center	Completed	No outcome recorded
Phase 2	NCT03448068 Background	Apr 2018 → Jan 2020	—	Mayo Clinic	Completed	No outcome recorded
Phase 2/33 trials
Phase 2/3	NCT01937247 Comparator	May 2018 → Oct 2020	—	American University of Beirut Medical Center	Completed	No outcome recorded
Phase 2/3	NCT02147054 Comparator	May 2014 → Jul 2016	organophosphate poisoning	University of Edinburgh	Completed	No outcome recorded
Phase 2/3	NCT01629394 Comparator	Jan → Oct 2012	morbid obesity	University of Patras	Unknown	No outcome recorded
Phase 37 trials
Phase 3	NCT03513406 Comparator	Mar 2018 → Mar 2023	—	University of Kansas Medical Center	Completed	No outcome recorded
Phase 3	NCT03116997 Comparator	Apr 2017 → Mar 2022	—	Memorial Sloan Kettering Cancer Center	Completed	No outcome recorded
Phase 3	NCT02666014 Comparator	Jun 2015 → Dec 2017	—	KK Women's and Children's Hospital	Completed	No outcome recorded
Phase 3	NCT02713113 Comparator	Mar 2015 → Feb 2016	—	Assiut University	Completed	No outcome recorded
Phase 3	NCT01962298 Comparator	Oct 2013 → Dec 2014	diaphragm disorder, myopathy	University Hospital, Antwerp	Completed	No outcome recorded
Phase 3	NCT01855217 Comparator	Apr 2013 → Apr 2014	—	St. Antonius Hospital	Unknown	No outcome recorded
Phase 3	NCT00751179 Comparator	Nov 2008 → Dec 2009	—	Merck Sharp & Dohme LLC	Completed	No outcome recorded

Phase 445 trials
Phase 4	NCT07666984 Comparator	Jun → Jul 2026 overdue	—	Cukurova University	Recruiting	No outcome recorded
Phase 4	NCT07203287 Comparator	Aug 2025 → Dec 2026 expected	—	The University of Texas Medical Branch, Galveston	Recruiting	No outcome recorded
Phase 4	NCT06112353 Comparator	Apr 2024 → Jul 2026 overdue	intestinal disorder	University of California, Irvine	Recruiting	No outcome recorded
Phase 4	NCT06225466 Comparator	Apr → Sep 2024	—	University of Texas Southwestern Medical Center	Completed	No outcome recorded
Phase 4	NCT06228092 Comparator	Dec 2023 → May 2025	curariform drugs toxicity	Matias Vested	Completed	No outcome recorded
Phase 4	NCT05545280 Comparator	Dec 2023 → Aug 2024	—	The Cleveland Clinic	Completed	No outcome recorded
Phase 4	NCT06035757 Comparator	Dec 2023 → Mar 2026	childhood acute lymphoblastic leukemia, delirium, strabismus	Konkuk University Medical Center	Completed	No outcome recorded
Phase 4	NCT05794503 Comparator	Sep 2023 → Jun 2024	urinary tract obstruction	University of Texas Southwestern Medical Center	Completed	No outcome recorded
Phase 4	NCT06081738 Comparator	Mar → Sep 2023	—	Menoufia University	Unknown	No outcome recorded
Phase 4	NCT04606901 Comparator	Apr 2021 → Jul 2023	chronic obstructive pulmonary disease	Temple University	Completed	No outcome recorded
Phase 4	NCT05468671 Background	Jan → Aug 2021	bronchial neoplasm	Zhejiang Cancer Hospital	Completed	No outcome recorded
Phase 4	NCT04570150 Comparator	Jan 2021 → Jan 2023	—	University of California, San Diego	Completed	No outcome recorded
Phase 4	NCT04332627 Comparator	Feb → May 2020	gallbladder disorder	Seoul National University Bundang Hospital	Completed	No outcome recorded
Phase 4	NCT03939923 Comparator	May 2019 → Jul 2021	coronary artery disorder	West Virginia University	Completed	No outcome recorded
Phase 4	NCT02825576 Comparator	Dec 2018 → Apr 2020	—	Northern Sydney Anaesthesia Research Institute	Terminated	No outcome recorded
Phase 4	NCT03574337 Comparator	Aug 2018	curariform drugs toxicity	Henry Ford Health System	Withdrawn	No outcome recorded
Phase 4	NCT03460509 Comparator	Aug 2018 → Dec 2019	curariform drugs toxicity, neuromuscular disease	The Hospital of Vestfold	Unknown	No outcome recorded
Phase 4	NCT03276026 Comparator	Feb → Nov 2018	respiratory system disorder	Virtua Health, Inc.	Terminated	No outcome recorded
Phase 4	NCT03087513 Comparator	Feb 2018 → Dec 2019	—	University Health Network, Toronto	Completed	No outcome recorded
Phase 4	NCT03591289 Comparator	Feb 2018	female reproductive system disorder, urinary system disorder	Rainer Lenhardt	Withdrawn	No outcome recorded
Phase 4	NCT03369782 Comparator	Dec 2017 → Apr 2018	—	Algemeen Ziekenhuis Maria Middelares	Withdrawn	No outcome recorded
Phase 4	NCT03168308 Comparator	Sep 2017 → Sep 2019	—	University of Texas Southwestern Medical Center	Completed	No outcome recorded
Phase 4	NCT03435003 Background	Aug 2017 → Mar 2019	—	Stony Brook University	Completed	No outcome recorded
Phase 4	NCT03226080 Comparator	Jul 2017 → Aug 2019	bone disorder	Loyola University	Withdrawn	No outcome recorded
Phase 4	NCT03034577 Comparator	Jun 2017 → Feb 2019	—	University of Melbourne	Completed	No outcome recorded
Phase 4	NCT03111121 Comparator	May 2017 → Jun 2018	—	West Virginia University	Completed	No outcome recorded
Phase 4	NCT02909439 Comparator	Nov 2016 → Nov 2017	—	Stony Brook University	Completed	No outcome recorded
Phase 4	NCT02794714 Comparator	Jun 2016 → Dec 2017	—	Kuala Lumpur General Hospital	Withdrawn	No outcome recorded
Phase 4	NCT02724111 Comparator	May 2016 → Feb 2017	vertebral column disorder	Korea University Guro Hospital	Completed	No outcome recorded
Phase 4	NCT02769325 Background	May 2016 → May 2017	—	Clinica Santa Maria	Unknown	No outcome recorded
Phase 4	NCT02455921 Comparator	Jun 2015 → Mar 2018	—	Attikon Hospital	Completed	No outcome recorded
Phase 4	NCT02390817 Comparator	Mar 2015 → Aug 2017	scoliosis	Cukurova University	Completed	No outcome recorded
Phase 4	NCT02247466 Comparator	Feb 2015 → Feb 2017	—	Herlev Hospital	Completed	No outcome recorded
Phase 4	NCT02414880 Comparator	Dec 2014 → Aug 2015	cirrhosis of liver	Cairo University	Completed	No outcome recorded
Phase 4	NCT02375217 Comparator	Oct 2014 → Oct 2015	—	American University of Beirut Medical Center	Completed	No outcome recorded
Phase 4	NCT02215382 Comparator	Aug → Oct 2014	ocular hypotension	Ordu University	Completed	No outcome recorded
Phase 4	NCT02286752 Comparator	Jun 2014 → Jan 2015	—	Ordu University	Completed	No outcome recorded
Phase 4	NCT02079337 Comparator	Nov 2013 → Apr 2014	—	Herlev Hospital	Completed	No outcome recorded
Phase 4	NCT01933425 Comparator	Aug 2013 → Apr 2014	—	Herlev Hospital	Completed	No outcome recorded
Phase 4	NCT05066035 Comparator	May 2013 → Oct 2016	curariform drugs toxicity	Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital	Completed	No outcome recorded
Phase 4	NCT01728584 Background	Nov 2012 → Apr 2014	gallbladder disorder	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT01972659 Background	Oct 2012 → Dec 2013	preeclampsia	Kocaeli University	Completed	No outcome recorded
Phase 4	NCT05313100 Comparator	Apr 2012 → Jan 2013	—	Duzce University	Completed	No outcome recorded
Phase 4	NCT01579851 Comparator	Jan 2012 → Jan 2015	—	Hopital Foch	Completed	No outcome recorded
Phase 4	NCT01453530 Comparator	Oct 2011 → Sep 2012	—	Radboud University Medical Center	Unknown	No outcome recorded

Phase not applicable21 trials
—	NCT07092046 Comparator	Aug 2025	—	Ankara City Hospital Bilkent	Completed	No outcome recorded
—	NCT06553066 Background	Aug 2024 → Aug 2026 overdue	—	University Hospital of Patras	Not yet recruiting	No outcome recorded
—	NCT05344417 Background	Mar 2024 → Dec 2026 expected	ileus	Ohio State University	Recruiting	No outcome recorded
—	NCT04944303 Comparator	Dec 2020 → Apr 2021	—	Second Affiliated Hospital of Guangzhou Medical University	Completed	No outcome recorded
—	NCT04471376 Comparator	Jul → Dec 2020	—	Beijing Tiantan Hospital	Completed	No outcome recorded
—	NCT04258007 Comparator	Jan → Nov 2020	—	Mansoura University	Completed	No outcome recorded
—	NCT04205097 Background	Dec 2019 → Dec 2020	gastric cancer	Ajou University School of Medicine	Completed	No outcome recorded
—	NCT04022733 Background	Oct 2019 → Aug 2021	abdominal wall malformation	Ajou University School of Medicine	Completed	No outcome recorded
—	NCT03791801 Comparator	Sep 2019 → Dec 2020	—	McGill University Health Centre/Research Institute of the McGill University Health Centre	Unknown	No outcome recorded
—	NCT04720573 Comparator	Jun → Oct 2019	—	Başakşehir Çam & Sakura City Hospital	Completed	No outcome recorded
—	NCT03871387 Background	Mar 2019 → Feb 2020	thyroid tumor	Yonsei University	Completed	No outcome recorded
—	NCT03795259 Comparator	Dec 2018 → May 2019	—	Istanbul University	Completed	No outcome recorded
—	NCT03292965 Comparator	Sep → Nov 2017	curariform drugs toxicity	Seoul National University Bundang Hospital	Completed	No outcome recorded
—	NCT02510157 Comparator	May 2015 → Sep 2016	—	Attikon Hospital	Completed	No outcome recorded
—	NCT02454504 Comparator	Mar 2015 → Aug 2016	—	Regina Elena Cancer Institute	Completed	No outcome recorded
—	NCT02697929 Comparator	Jan 2014 → Jan 2019	curariform drugs toxicity	Azienda Ospedaliera S. Maria della Misericordia	Completed	No outcome recorded
—	NCT01980069 Comparator	Nov 2013 → Oct 2014	—	Yonsei University	Completed	No outcome recorded
—	NCT01503840 Comparator	Dec 2011 → Jun 2012	respiratory paralysis	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Completed	No outcome recorded
—	NCT01902641 Comparator	Oct 2011 → Mar 2012	pharyngitis	Dr. Horst Schmidt Klinik GmbH	Completed	No outcome recorded
—	NCT01301261 Comparator	Dec 2010 → Feb 2013	—	University of Athens	Unknown	No outcome recorded
—	NCT02419352 Comparator	Sep 2010 → Dec 2015	—	Attikon Hospital	Completed	No outcome recorded

Evidence & citations 18 cited values

Every value below carries the sentence it was read from. 245 sources stand behind the page.

Field	Value	Cited text
Known as	Sugammadex	“Sugammadex is a modified cyclodextrin that forms complexes with rocuronium, reducing free plasma concentrations of rocuronium and reversing its neuromuscular blocking action...” NCT02794714 ↗ 238 “At the end of surgery, deep Block patients' will receive 4 mg/kg sugammadex and the patient's trachea will be extubated according to routine extubation criteria.” NCT03591289 ↗ “Depending on depth of block (subjectively assessed by TOF response), Neostigmine, Sugammadex, or no reversal drug is used to reverse block prior to extubation.” NCT03543826 ↗ “Sugammadex is a modified γ-cyclodextrin that reverses the effect of the steroidal nondepolarizing neuromuscular blocking agents rocuronium and vecuronium (2).” NCT03791801 ↗ “Sugammadex is administered at the end of surgery after assessment of the level of neuromuscular blockade is done.” NCT06035757 ↗ “Used for Neuromuscular reversal; Sugammadex is devoid of the parasympathetic effects caused by Neostigmine.” NCT04096144 ↗ “After the end of surgery, sugammadex of 4 mg/kg will be administered to reverse neuromuscular blockade.” NCT02762890 ↗ “Reversal of the TOF=2 will be done by Sugammadex 2 mg/kg at end of procedure (Time of last suture)” NCT03643913 ↗ “Specific Neuromuscular Blockade reversal will be performed with Sugammadex intravenously.” NCT02546843 ↗ “sugammadex 4 mg/kg are administered IV for reversal of neuromuscular block” NCT02100280 ↗ “At the end of surgery, IV Sugammadex (Bridion®, Merck Sharp and Dohme” NCT03871387 ↗ “reversal using sugammadex 4 mg/kg based on actual body weight” NCT04022733 ↗ “Sugammadex: will be used for the other arms in the study.” NCT05344417 ↗ “sugammadex 2mg/kg or 4 mg/kg dose depending on twitch” NCT03448068 ↗ “Using rocuronium and reversal with sugammadex” NCT02648503 ↗ “Reversal of the block with sugammadex.” NCT02513693 ↗ “Rocuronium and Sugammadex” NCT06553066 ↗ NCT00559468 ↗ NCT05354466 ↗ NCT05028088 ↗ NCT03196791 ↗ NCT00591409 ↗ NCT07309393 ↗ NCT03138967 ↗ NCT05246397 ↗ NCT03909165 ↗ NCT02708056 ↗ NCT07534475 ↗ NCT00988065 ↗ NCT04471376 ↗ NCT01972659 ↗ NCT03196167 ↗ NCT01728584 ↗ NCT03958201 ↗ NCT02410590 ↗ NCT04546672 ↗ NCT03911232 ↗ NCT03795259 ↗ NCT02939430 ↗ NCT03116997 ↗ NCT03369782 ↗ NCT01422304 ↗ NCT03292965 ↗ NCT03346070 ↗ NCT05724550 ↗ NCT03137290 ↗ NCT02247466 ↗ NCT02728726 ↗ NCT02011490 ↗ NCT01564576 ↗ NCT01761552 ↗ NCT02375217 ↗ NCT02944175 ↗ NCT02243943 ↗ NCT04566796 ↗ NCT04997759 ↗ NCT01453530 ↗ NCT04263363 ↗ NCT00751179 ↗ NCT02580188 ↗ NCT02414880 ↗ NCT01142648 ↗ NCT00675792 ↗ NCT04570150 ↗ NCT05328778 ↗ NCT04545099 ↗ NCT01902641 ↗ NCT00591786 ↗ NCT02390817 ↗ NCT03229486 ↗ NCT00826176 ↗ NCT03351608 ↗ NCT06136585 ↗ NCT05723406 ↗ NCT03322657 ↗ NCT02329964 ↗ NCT02568345 ↗ NCT01539044 ↗ NCT04556721 ↗ NCT06081738 ↗ NCT00420680 ↗ NCT07666984 ↗ NCT01161004 ↗ NCT01933425 ↗ NCT05751603 ↗ NCT00473694 ↗ NCT01570179 ↗ NCT02455921 ↗ NCT00482599 ↗ NCT02825576 ↗ NCT03904550 ↗ NCT03435003 ↗ NCT00825812 ↗ NCT04161508 ↗ NCT04407078 ↗ NCT03574337 ↗ NCT01424488 ↗ NCT00421148 ↗ NCT06794450 ↗ NCT06982092 ↗ NCT02724111 ↗ NCT05040490 ↗ NCT04332627 ↗ NCT05985343 ↗ NCT00552929 ↗ NCT02079337 ↗ NCT02454504 ↗ NCT06398899 ↗ NCT01785758 ↗ NCT00552617 ↗ NCT02510157 ↗ NCT03513406 ↗ NCT06634355 ↗ NCT03728543 ↗ NCT07203287 ↗ NCT04720573 ↗ NCT02284412 ↗ NCT04854993 ↗ NCT01479764 ↗ NCT02109133 ↗ NCT01937247 ↗ NCT00702715 ↗ NCT00758485 ↗ NCT00298831 ↗ NCT05545280 ↗ NCT02147054 ↗ NCT03144453 ↗ NCT00474253 ↗ NCT03381209 ↗ NCT01050543 ↗ NCT06228092 ↗ NCT04258007 ↗ NCT03460509 ↗ NCT05817019 ↗ NCT02666014 ↗ NCT03226080 ↗ NCT03515694 ↗ NCT00451217 ↗ NCT03108989 ↗ NCT03944473 ↗ NCT00953550 ↗ NCT00451100 ↗ NCT02419352 ↗ NCT01509651 ↗ NCT02028065 ↗ NCT03112993 ↗ NCT03519724 ↗ NCT05256901 ↗ NCT02451202 ↗ NCT03943888 ↗ NCT04131218 ↗ NCT02403063 ↗ NCT02286752 ↗ NCT03519854 ↗ NCT05993390 ↗ NCT02215382 ↗ NCT03034577 ↗ NCT01579851 ↗ NCT03087513 ↗ NCT04944303 ↗ NCT01301261 ↗ NCT05202899 ↗ NCT06112353 ↗ NCT00474617 ↗ NCT03168308 ↗ NCT03039543 ↗ NCT05664633 ↗ NCT03420937 ↗ NCT03579589 ↗ NCT01718236 ↗ NCT05276804 ↗ NCT05313100 ↗ NCT03923556 ↗ NCT02769325 ↗ NCT03519633 ↗ NCT05801679 ↗ NCT01911520 ↗ NCT06225466 ↗ NCT04205097 ↗ NCT07092046 ↗ NCT02909439 ↗ NCT03346057 ↗ NCT03939923 ↗ NCT07477132 ↗ NCT02160223 ↗ NCT02484651 ↗ NCT03634956 ↗ NCT00656799 ↗ NCT00535496 ↗ NCT00535743 ↗ NCT06678451 ↗ NCT02545595 ↗ NCT03679611 ↗ NCT01980069 ↗ NCT01855217 ↗ NCT00724932 ↗ NCT01101139 ↗ NCT06210165 ↗ NCT03689413 ↗ NCT04347486 ↗ NCT03583021 ↗ NCT03532178 ↗ NCT05718934 ↗ NCT02256280 ↗ NCT03111121 ↗ NCT00475215 ↗ NCT04606901 ↗ NCT03210376 ↗ NCT01748643 ↗ NCT02861131 ↗ NCT01629394 ↗ NCT04608682 ↗ NCT02860507 ↗ NCT01965067 ↗ NCT00895609 ↗ NCT02845375 ↗ NCT07271875 ↗ NCT05661409 ↗ NCT03328312 ↗ NCT01503840 ↗ NCT01809886 ↗ NCT02698969 ↗ NCT06575036 ↗ NCT02713113 ↗ NCT05066035 ↗ NCT06334562 ↗ NCT05794503 ↗ NCT01890057 ↗ NCT03996655 ↗ NCT05187455 ↗ NCT06436768 ↗ NCT03276026 ↗ NCT05887375 ↗ NCT06962007 ↗ NCT02361060 ↗ NCT02697929 ↗ NCT01962298 ↗ NCT03803982 ↗ NCT00379613 ↗
Known as	Bridion	“In sugammadex group, sugammadex (Bridion, Merck Shart and Dohme (MSD), Oss, the Netherlands) will be administered intravenously in different doses according to the degree of...” NCT01980069 ↗ 11 “At present, the introduction of sugammadex (Bridion®), an antagonist of nondepolarizing the neuromuscular relaxant rocuronium, may lead to an extraordinary breakthrough.” NCT01809886 ↗ “Sugammadex (Bridion®) is a novel drug which selectively binds rocuronium (Esmeron®).” NCT01911520 ↗ “Rocuronium: Zemuron. Sugammadex: Bridion. Succinylcholine: Suxamethonium” NCT03532178 ↗ “At the end of surgery, IV Sugammadex (Bridion®, Merck Sharp and Dohme” NCT03871387 ↗ “Group A - Sugammadex (Bridion®) 2 mg/kg,” NCT03328312 ↗ “Sugammadex Injection [Bridion]” NCT03087513 ↗ “Sugammadex (tradename Bridion)” NCT01761552 ↗ “Sugammadex Injection [Bridion]” NCT03229486 ↗ “Sugammadex Injection [Bridion]” NCT03996655 ↗ “Sugammadex Injection [Bridion]” NCT03515694 ↗ “sugammadex, Bridion” NCT01564576 ↗
Known as	HengShu, Sugammadex sodium	“HengShu, Sugammadex sodium” NCT07309393 ↗
Known as	MK-8616	“sugammadex (Org 25969; MK-8616)” NCT03519854 ↗ 1 NCT03519867 ↗
Known as	Org 25969	“sugammadex (Org 25969; MK-8616)” NCT03519854 ↗
Known as	Org 25969, Bridion	“Org 25969, Bridion®” NCT00826176 ↗
Known as	SUG	“Sugammadex (SUG) is a novel-specific antagonist of aminosteroidal muscle relaxants, which can effectively antagonise muscle relaxants at different depths.” PMID 35105573 ↗ Feb 2022
Known as	Sugammadex adroiq	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	Sugammadex amomed	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	Sugammadex fresenius kabi	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	Sugammadex mylan	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	Sugammadex octasodium salt	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	Sugammadex piramal	ChEMBL registry synonym — accepted as the source's own label CHEMBL2111107 ↗
Known as	sugammadex sodium	“This study administers sugammadex sodium to pediatric patients under general anesthesia with rocuronium.” NCT04347486 ↗ 3 “Drug: Sugammadex Sodium” NCT03196791 ↗ NCT02888067 ↗ NCT05468671 ↗
Known as	sugammadex: Bridion	“sugammadex: Bridion” NCT01748643 ↗
Action	Inhibit	“Sugammadex, a cyclodextrin molecule that encapsulates and inactivates rocuronium and vecuronium” NCT01748643 ↗
Modality	Other / unclassified	“sugammadex, a modified gamma-cyclodextrin derivative” PMID 17667567 ↗ Aug 2007
Route	Intravenous	“sugammadex 2.0 to 16.0 mg/kg IV was administered” NCT00379613 ↗